Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers
Sponsor: AlphaMol Science Ltd. (Shanghai)
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of Alpha-0261 tablets after single oral administration in healthy adult volunteers.
Official title: A Randomized, Double-blind, Placebo-Controlled, Dose-Escalation, Phase Ia Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Oral Administration of Alpha-0261 Tablets in Adult Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-07-21
Completion Date
2026-05-30
Last Updated
2025-12-12
Healthy Volunteers
Yes
Conditions
Interventions
Alpha-0261
Oral, tablet
Placebo
Oral, tablet
Locations (1)
Bishan Hospital of Chongqing
Chongqing, China